'A special day': End of Pfizer trial paves way for a COVID shot this year
Final results from Pfizer Inc's COVID-19 vaccine trial showed its shot had a 95% success rate and two months of safety data, paving the way for the drugmaker to apply for an emergency U.S. authorization within days, it said on Wednesday. Soraya Ali reports.
UP NEXT
NOW PLAYING: other
'A special day': End of Pfizer trial paves way for a COVID shot this year
Reuters
UP NEXT
-
Pandoro Pudding
Australian Women's Weekly
-
Brussel Sprout Salad
-
Potato Gnocchi
-
Pfizer vaccine appears effective against coronavirus variant found in Britain - study
Reuters
-
European countries struggle to make most of Pfizer COVID-19 vaccine doses
-
Supermarket chain Aldi to pay U.S. workers who get COVID-19 vaccination
-
Brazil to begin vaccination campaign on Monday afternoon
-
Brazil vaccinations start as country faces vaccine ingredient shortfall
-
Brazil vaccinations start as country faces vaccine ingredient shortfall
-
Vaccine nationalism puts world on brink of 'catastrophic moral failure': WHO chief
-
UK says vaccine manufacturing is 'lumpy' but still on course for targets
-
'Go for it,' says first person vaccinated in India's massive COVID-19 campaign
-
'Go for it,' says first person vaccinated in India's massive COVID-19 campaign
-
Vaccine shortages arise across U.S., halting inoculations in some places
-
Trump administration accused of deception in pledging release of vaccine stockpile
-
Fast-spreading UK coronavirus variant could be dominant in U.S. by March, CDC says
![image beacon](https://web.vortex.data.msn.com/collect/v1/t.gif?name=%27Ms.Webi.PageView%27&ver=%272.1%27&appId=%27JS%3AMSN%27&ext-app-env=%27prod%27&ext-javascript-libver=%274.0.0-beta-10%27&ext-user-localId=%27t%3A2ED5B0C4C316699638FCBF02C2C868D5%27&*baseType=%27Ms.Content.PageView%27&*isJs=False&*title=%27%27&*isLoggedIn=False&*isManual=True&*serverImpressionGuid=%2717182bdc-00f0-423e-9f9f-328010581f5f%27&-ver=%271.0%27&-impressionGuid=%2717182bdc-00f0-423e-9f9f-328010581f5f%27&-pageName=%27channelplayerpage%27&-uri=%27http%253A%252F%252Fwww.msn.com%252Fen-au%252Flifestyle%252Fother%252Fa-special-day-end-of-pfizer-trial-paves-way-for-a-covid-shot-this-year%252Fvi-BB1b8GeX%27&-referrerUri=%27%27&-pageTags=%27{"pg.t"%3A"video"%2C"pg.p"%3A"prime"%2C"pg.c"%3A""%2C"ex"%3A""%2C"rid"%3A"17182bdc00f0423e9f9f328010581f5f"%2C"clid"%3A"2ED5B0C4C316699638FCBF02C2C868D5"%2C"clidType"%3A"muid"%2C"di"%3A"19552"%2C"partner"%3A"Reuters"%2C"publcat"%3A"Reuters%2BNews%2B%2526%2BMedia%2BInc."%2C"cvs"%3A"Browser"%2C"subcvs"%3A"lifestyle"%2C"entityId"%3A"BB1b8GeX"%2C"entitySrc"%3A"vi"%2C"provid"%3A"AAf3a78"%2C"dpt"%3A"other"%2C"sdpt"%3A""%2C"ar"%3A"0"%2C"dgk"%3A"downlevel.pc"%2C"imd"%3A"0"%2C"parentId"%3A""%2C"pgIdx"%3A""%2C"pgTot"%3A""%2C"anoncknm"%3A""%2C"afd"%3A""%2C"issso"%3A"0"%2C"aadState"%3A"0"}%27&-behavior=0&-market=%27en-au%27){kind=small}